LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

FHS
May 20, 2024
5:30 pm

Announcing a new article publication for Zoonoses journal. The global coronavirus disease 2019 (COVID-19) pandemic was caused by SARS-CoV-2.

Evotec partners with X-Chem for tech-enabled drug discovery

The collaboration will use DEL technology and machine learning to boost early-stage drug discovery. Credit: Gorodenkoff/Shutterstock. German life science company Evotec has announced a collaboration

September 6, 2024

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Researchers conducted a prospective cohort analysis over two years.

September 8, 2023

Researchers discover key functions of IRF1 in cancer progression and treatment response

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.